Publication | Closed Access
Specific glucocorticoid-binding macromolecules from mouse fibroblasts growing in vitro. A possible steroid receptor for growth inhibition.
131
Citations
0
References
1970
Year
Human GrowthSpecific Glucocorticoid-binding MacromoleculesBinding ComponentGlucocorticoidCell GrowthCellular PhysiologyGrowth InhibitionFibroblast Growth FactorCell SignalingFrozen StorageSteroid MetabolismGrowth HormoneBiochemistryPossible Steroid ReceptorEndocrinologyPharmacologyCell BiologyNatural SciencesCellular BiochemistryMedicineDrug DiscoveryExtracellular Matrix
Mouse fibroblasts growing in vitro (L cells) contain a binding component for triamcinolone acetonide which is apparently distributed intracellularly, largely as a cytoplasmic soluble macromolecule. The structure-activity relationships of steroids active in growth inhibition are exactly paralleled by their ability to displace 3H-triamcinolone acetonide from this binding component. The binding component is saturated between 10-8 and 5 x 10-8 M triamcinolone acetonide. The macromolecules bind unchanged triamcinolone acetonide noncovalently, and the steroid is released from binding by brief digestion with a proteolytic enzyme. Cells which are resistant to glucocorticoids bind much less triamcinolone acetonide in a specific manner (i.e., displaceable by glucocorticoids) than do sensitive cells. The binding component therefore satisfies many of the rigorous criteria necessary for assignment as a receptor for the growth-inhibitory action of glucocorticoids on mouse fibroblasts. In addition, triamcinolone acetonide bound to the 105,000 x g supernatant fraction remains bound under conditions of frozen storage for at least 1 month.